Last reviewed · How we verify
NCT04107363
Oropharyngeal Aspiration to Reduce Ventilator-Related Pneumonia
NA trial testing Oropharyngeal aspiration before changing the position of the patient in Ventilator-associated Bacterial Pneumonia in 40 participants. Completed in 30 June 2019.
30 April 2019
Quick facts
| Lead sponsor | Ayşe AKBIYIK |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 40 |
| Start date | 1 July 2015 |
| Primary completion | 30 April 2019 |
| Estimated completion | 30 June 2019 |
Drugs / interventions tested
- Oropharyngeal aspiration before changing the position of the patient
- Control group:
Conditions studied
- Ventilator-associated Bacterial Pneumonia — all drugs for Ventilator-associated Bacterial Pneumonia →
Sponsor
Ayşe AKBIYIK
Who can join
18 and older, any sex, with Ventilator-associated Bacterial Pneumonia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Ventilator-associated pneumonia (VAP) is one of the healthcare-related infections that is common in critically ill patients, prolongs hospital stay, significantly increases mortality and additional health care costs. Microaspiration of oropharyngeal secretions the primary pathway in the formation of VAP has led researchers to focus on the detection of applications to prevent microbial colonization. Continuous or intermittent oropharyngeal aspiration, open system aspiration versus closed system aspiration, extensive oral care, oropharyngeal aspiration prior to patient positioning are some of these applications. When the patient is turned to position, the outbreak accumulated in the oral cavity is more likely to move to the lower respiratory tract. In this study, it is assumed that aspiration of oropharyngeal secretions prior to each position change will reduce the accumulation of oral secretion in the endotracheal tube cuff and reduce aspiration of contaminated secretion and reduce the risk of developing VIP. This randomized controlled experimental study was planned to confirm the validity of this assumption. This study was a randomized controlled experimental study designed to investigate the effect of oropharyngeal aspiration on decreasing the incidence of ventilator-associated pneumonia in patients receiving mechanical ventilation. The research was conducted between July 2015 and April 2019 in anesthesiology and reanimation intensive care unit. The study was carried out with 20 patients who underwent oropharyngeal aspiration as needed and 20 patients with oropharyngeal aspiration prior to each change of position.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
The effect of oropharyngeal aspiration before position change on reducing the incidence of ventilator- associated pneumonia.
Akbiyik A, Hepçivici Z, Eşer I, Uyar M, et al · · 2021 · cited 6× · PMID 33230628 · DOI 10.1007/s10096-019-03789-4
Verify or expand the search:
- PubMed search for NCT04107363
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Ayşe AKBIYIK trials
Trials by the same sponsor.
- NCT04103229 — Urinary Leakage in the Indwelling Urinary Catheterization · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04107363 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ayşe AKBIYIK
- Last refreshed: 27 September 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04107363.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing